Salesforce continues to support India through Covid-19 crisis

0
Covid

Salesforce announced a US$ 1.1 million donation to United Way of Hyderabad, Concern India Foundation, Rise Against Hunger India and Youth for Seva, to support the Covid-19 response across India. These organisations are focused on procuring medical equipment and supplies, administering vaccine awareness and distribution, building community isolation centers and providing food security for the most vulnerable populations in the country.

A global employee giving and matching campaign through GiveIndia will further contribute to supporting various organisations in India. To date the campaign generated more than US$ one million including the matching by Salesforce. Through corporate and employee donations, Salesforce will impact the lives of more than 2,00,000 people across the country.

In addition, Salesforce partnered with HSBC and the Khosla family to deliver medical supplies to different cities across the country. In total, 6000+ oxygen concentrators, 10,000 pulse oximeters will be delivered to critical locations through partnerships with the Red Cross and GiveIndia. Oxygen concentrators will also be available to all employees of Salesforce in India and outside of India with families here.

“Over the last one year, we have demonstrated the power of businesses as a platform for change and the current Covid-19 crisis in India underscores how deeply interconnected we all are. The need of the hour for a future-ready India is vaccinations and I cannot emphasise enough the role of technology in the management of vaccines. I urge the healthcare system to leverage the power of technology to ensure equitable and speedy distribution of vaccines as it is the only way we will effectively end the global pandemic. I am grateful to our team and our partners globally for their support to India while we continue to help the community, our team and their loved ones during this difficult time,” said Arundhati Bhattacharya, CEO and Chairperson, Salesforce India.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here